Search Within

David Hyman

  1. "Maria Arcila"
Formats
  1. Meeting Abstract (33)
  2. Journal Article (24)
Groups
  1. Department of Medicine (57)
  2. Department of Pathology and Laboratory Medicine (57)
  3. Early Drug Development Service (57)
  4. Solid Tumor Oncology Division (57)
  5. GSK Faculty (55)
  6. Human Oncology and Pathogenesis Program (49)

More Groups

People
  1. Maria Arcila (57)
  2. Michael Berger (41)
  3. Marc Ladanyi (38)
  4. David Solit (36)
  5. Ahmet Zehir (35)
  6. Jose Baselga (23)

More People

Years
  1. 2020 (4)
  2. 2019 (6)
  3. 2018 (8)
  4. 2017 (15)
  5. 2016 (7)
  6. 2015 (16)

More Years

Publications
  1. Journal of Clinical Oncology (17)
  2. Blood (6)
  3. Cancer Discovery (4)
  4. Cancer Research (3)
  5. Clinical Cancer Research (3)
  6. JAMA Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (18)
  2. American Association for Cancer Research (11)
  3. American Society of Hematology (6)
  4. Nature Publishing Group (6)
  5. American Medical Association (4)
  6. Nature Research (3)

More Publishers

Results (57)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Population-scale identification of clonal hematopoiesis derived mutations in solid tumor mutation profiling
    Meeting Abstract

    Ptashkin, R.; Coombs, C. C.; Hyman, D. M.; Solit, D.; Baselga, J.; Arcila, M. E.; Ladanyi, M.; Levine, R. L.; Berger, M. F.; Zehir, A.
    Blood (2017)

    Fulltext@MSK | Save
  • Diverse BRCA1 and BRCA2 reversion mutations in circulating cell-free DNA of therapy-resistant breast or ovarian cancer
    Journal Article

    Weigelt, B.; Comino-MeĢndez, I.; de Bruijn, I.; Tian, L.; Meisel, J. L.; Garcia-Murillas, I.; Fribbens, C.; Cutts, R.; Martelotto, L. G.; Ng, C. K. Y.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes
    Journal Article

    Coombs, C. C.; Zehir, A.; Devlin, S. M.; Kishtagari, A.; Syed, A.; Jonsson, P.; Hyman, D. M.; Solit, D. B.; Robson, M. E.; Baselga, J.; more...
    Cell Stem Cell (2017)

    Fulltext@MSK | Save
  • Pan-TRK immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions
    Journal Article

    Hechtman, J. F.; Benayed, R.; Hyman, D. M.; Drilon, A.; Zehir, A.; Frosina, D.; Arcila, M. E.; Dogan, S.; Klimstra, D. S.; Ladanyi, M.; more...
    American Journal of Surgical Pathology (2017)

    Fulltext@MSK | Save
  • Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Journal Article

    Mandelker, D.; Zhang, L.; Kemel, Y.; Stadler, Z. K.; Joseph, V.; Zehir, A.; Pradhan, N.; Arnold, A.; Walsh, M. F.; Li, Y.; more...
    JAMA - Journal of the American Medical Association (2017)

    Fulltext@MSK | Save
  • DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma
    Journal Article

    Teo, M. Y.; Bambury, R. M.; Zabor, E. C.; Jordan, E.; Al-Ahmadie, H.; Boyd, M. E.; Bouvier, N.; Mullane, S. A.; Cha, E. K.; Roper, N.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
    Journal Article

    Zehir, A.; Benayed, R.; Shah, R. H.; Syed, A.; Middha, S.; Kim, H. R.; Srinivasan, P.; Gao, J.; Chakravarty, D.; Devlin, S. M.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save
  • Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies
    Journal Article

    Jordan, E. J.; Kim, H. R.; Arcila, M. E.; Barron, D.; Chakravarty, D.; Gao, J. J.; Chang, M. T.; Ni, A.; Kundra, R.; Jonsson, P.; more...
    Cancer Discovery (2017)

    Fulltext@MSK | Save
  • Pan-TRK IHC is an efficient and reliable screening assay for targetable NTRK fusions
    Meeting Abstract

    Hechtman, J. F.; Drilon, A.; Hyman, D. M.; Zehir, A.; Dogan, S.; Arcila, M. E.; Ladanyi, M.; Benayed, R.; Jungbluth, A.
    Modern Pathology (2017)

    Fulltext@MSK | Save
  • Genomic landscape and clinical features of carcinomas with ERBB2 S310 extracellular domain mutations
    Meeting Abstract

    Desmeules, P.; Zehir, A.; Hyman, D. M.; Arcila, M. E.; Ladanyi, M.
    Modern Pathology (2017)

    Fulltext@MSK | Save